Press Releases MaaT Pharma selected in the Big Booster TOP 10 MaaT Pharma, which develops the first treatment using an autologous intestinal microbiota transplant is now…MaaT PharmaFebruary 16, 2016
Press Releases MaaT Pharma accelerates its development with the closing of EUR 1 M in second fundraising Important step in developing microbiome therapy for severe intestinal Dysbiosis.MaaT PharmaJuly 24, 2015
Press Releases MaaT Pharma™ raises EUR 1 M (USD 1.25M) in First Investment Round Financing to develop microbiome therapy for severe intestinal dysbiosisMaaT PharmaJanuary 12, 2015
